Unexpected TTF-1 positivity in a subset of gastric adenocarcinomas

Applied Immunohistochemistry and Molecular Morphology

Volumn 24, Issue 8, 2016, Pages 603-607

  Choi, Sarah M ^a   Furth, Emma E ^a   Zhang, Paul J ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Esophageal adenocarcinoma; Gastric adenocarcinoma; Napsin; TTF 1

Indexed keywords

NUCLEAR PROTEIN; PARAFFIN; THYROID NUCLEAR FACTOR 1; TRANSCRIPTION FACTOR;

ADENOCARCINOMA; HUMAN; METABOLISM; METASTASIS; PATHOLOGY; STOMACH TUMOR;

ADENOCARCINOMA; HUMANS; NEOPLASM METASTASIS; NUCLEAR PROTEINS; PARAFFIN EMBEDDING; STOMACH NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 84944339174     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0000000000000244     Document Type: Article

References (10)

1. Lau SK, Luthringer DJ, Eisen RN. Thyroid transcription factor-1: a review. Appl Immunohistochem Mol Morphol. 2002;10: 97-102.
2. Onofre AS, Pomjanski N, Buckstegge B, et al. Immunohistochemical diagnosis of hepatocellular carcinoma and identification of carcinomas of unknown primary metastatic to the liver on fineneedle aspiration cytologies. Cancer. 2007;111:259-268.
3. Turner BM, Cagle PT, Sainz IM, et al. Napsin A, a new marker for lung adenocarcinoma, is complementary and more sensitive and specific than thyroid transcription factor 1 in the differential diagnosis of primary pulmonary carcinoma: evaluation of 1674 cases by tissue microarray. Arch Pathol Lab Med. 2012;136: 163-171.
4. Zhang PJ, Gao HG, Pasha TL, et al. TTF-1 expression in ovarian and uterine epithelial neoplasia and its potential significance, an immunohistochemical assessment with multiple monoclonal antibodies and different secondary detection systems. Int J Gynecol Pathol. 2009;28:10-18.
5. Compérat E, Zhang F, Perrotin C, et al. Variable sensitivity and specificity of TTF-1 antibodies in lung metastatic adenocarcinoma of colorectal origin. Mod Pathol. 2005;18:1371-1376.
6. Aulakh KS, Chisholm CD, Smith DA, et al. TTF-1 and napsin A do not differentiate metastatic lung adenocarcinomas from primary esophageal adenocarcinomas: proposal of a novel staining panel. Arch Pathol Lab Med. 2013;137:1094-1098.
7. Matoso A, Singh K, Jacob R, et al. Comparison of thyroid transcription factor-1 expression by 2 monoclonal antibodies in pulmonary and nonpulmonary primary tumors. Appl Immunohistochem Mol Morphol. 2010;18:142-149.
8. Surrey LF, Frank R, Zhang PJ, et al. TTF-1 and Napsin-A are expressed in a subset of cholangiocarcinomas arising from the gallbladder and hepatic ducts: continued caveats for utilization of immunohistochemistry panels. Am J Surg Pathol. 2014;38:224-227.
9. Theodoropoulos DS, Ledford DK, Lockey RF. Expression of the lung-specific thyroid transcription factor (TTF-1) within the tracheoesophageal fistula of embryo rats exposed to Adriamycin. J Pediatr Surg. 2000;35:811-812.
10. Pang Y, von Turkovich M, Wu H, et al. The binding of thyroid transcription factor-1 and hepatocyte paraffin 1 to mitochondrial proteins in hepatocytes: a molecular and immunoelectron microscopic study. Am J Clin Pathol. 2006;125:722-726.